Thrombolysis for acute deep vein thrombosis
L Watson, C Broderick… - Cochrane Database of …, 2016 - cochranelibrary.com
Background Standard treatment for deep vein thrombosis aims to reduce immediate
complications. Use of thrombolysis or clot dissolving drugs could reduce the long‐term …
complications. Use of thrombolysis or clot dissolving drugs could reduce the long‐term …
Guidance for the prevention and treatment of the post-thrombotic syndrome
The post-thrombotic syndrome (PTS) is a frequent, potentially disabling complication of deep
vein thrombosis (DVT) that reduces quality of life and is costly. Clinical manifestations …
vein thrombosis (DVT) that reduces quality of life and is costly. Clinical manifestations …
Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis
Background The post-thrombotic syndrome frequently develops in patients with proximal
deep-vein thrombosis despite treatment with anticoagulant therapy. Pharmacomechanical …
deep-vein thrombosis despite treatment with anticoagulant therapy. Pharmacomechanical …
The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association
Methods Members of the writing panel were invited by the American Heart Association
Scientific Council leadership because of their multidisciplinary expertise in PTS. Writing …
Scientific Council leadership because of their multidisciplinary expertise in PTS. Writing …
Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled …
Y Haig, T Enden, O Grøtta, NE Kløw… - The Lancet …, 2016 - thelancet.com
Background Post-thrombotic syndrome is a common complication after acute proximal deep
vein thrombosis (DVT) and is associated with reduced quality of life and a substantial cost …
vein thrombosis (DVT) and is associated with reduced quality of life and a substantial cost …
Endovascular thrombus removal for acute iliofemoral deep vein thrombosis: analysis from a stratified multicenter randomized trial
Background: The ATTRACT trial (Acute Venous Thrombosis: Thrombus Removal with
Adjunctive Catheter-Directed Thrombolysis) previously reported that pharmacomechanical …
Adjunctive Catheter-Directed Thrombolysis) previously reported that pharmacomechanical …
The post-thrombotic syndrome
SR Kahn - Hematology 2014, the American Society of …, 2016 - ashpublications.org
The post-thrombotic syndrome (PTS) is a frequent, sometimes disabling complication of
deep vein thrombosis (DVT) that reduces quality of life and is costly. This article discusses …
deep vein thrombosis (DVT) that reduces quality of life and is costly. This article discusses …
[HTML][HTML] Quality of life after pharmacomechanical catheter-directed thrombolysis for proximal deep venous thrombosis
Background After deep venous thrombosis (DVT), many patients have impaired quality of life
(QOL). We aimed to assess whether pharmacomechanical catheter-directed thrombolysis …
(QOL). We aimed to assess whether pharmacomechanical catheter-directed thrombolysis …
[HTML][HTML] Catheter-directed thrombolysis of deep vein thrombosis: literature review and practice considerations
D Fleck, H Albadawi, F Shamoun… - Cardiovascular …, 2017 - ncbi.nlm.nih.gov
Deep vein thrombosis (DVT) is a major health problem worldwide. The risk of pulmonary
embolism following DVT is well established, but the long-term vascular sequelae of DVT are …
embolism following DVT is well established, but the long-term vascular sequelae of DVT are …
Treatment of cancer-associated thrombosis
AYY Lee, EA Peterson - Blood, The Journal of the American …, 2013 - ashpublications.org
Therapeutic options for the management of venous thromboembolism (VTE) in patients with
cancer remain very limited. Although low-molecular-weight heparin monotherapy has been …
cancer remain very limited. Although low-molecular-weight heparin monotherapy has been …